Aros Pharma

Copenhagen, Capital Region, Denmark

http://www.arospharma.com/

Company profile

Aros Pharma company profile

Aros Pharma is developing a new effective therapy reducing the pain associated with Irritable Bowel Syndrome (IBS). The company has acquired all rights to a new chemical entity that can negatively modulate the activity of acid sensors in the gastrointestinal tract. These acid sensors are believed to play a central role in pain associated with IBS.

Business identity

Website: http://www.arospharma.com/
Operating status: Closed
Company type: For Profit
Employee range: 00001-00010 employees
Revenue range: $100K+
Founded: 2009-01-01

Headquarters

Headquarters: Copenhagen, Capital Region, Denmark
Postal code: 2200
Country code: DK
Continent: Europe

Capital profile

Funding and company signals

Funding rounds: 1
Last funding: Series Unknown / 2010-12-21
Last equity funding: Series Unknown
Investors: 1
Closed on: 2016-10-14

Categories and groups

Developer Tools Medical Pharmaceutical Health Care Software

Founders and investors

Investors

Seed Capital

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.